Noninvasive assessment of the carotid and cerebrovascular atherosclerotic plaques by multidetector CT in type-2 diabetes mellitus patients with transient ischemic attack or stroke
© He et al; licensee BioMed Central Ltd. 2013
Received: 10 July 2012
Accepted: 20 February 2013
Published: 26 February 2013
The cerebrovasuclar artery disease as a common complication of type-2 diabetes mellitus (T2DM) caused huge economic burden and lives threatening to patients. We evaluated the prevalence and morphology of carotid and cerebrovascular atherosclerotic plaques in T2DM patients with transient ischemic attack (TIA) or stroke using multidetector CT (MDCT).
64-MDCT and dual-source CT (DSCT) angiographies were performed in 195 T2DM patients with TIA or stroke (mean age 65.7+/-12.8 years; 118 men) between January 2009 to August 2011. During the process, plaque type, its distribution, extensive and obstructive natures were determined for each segment derived from the patients.
Atherosclerotic plaques were detected in 183 (93.8%) patients. A total of 1056 segments with plaque were identified, of which 450 (42.6%) were non-calcified, 192 (18.2%) were mixed and 414 (39.2%) calcified ones. Among them, 562 (53.2%) resulted in mild stenosis, 291 (27.6%) moderate stenosis, 170 (16.1%) severe stenosis and 33 (3.1%) occlusion. Non-calcified plaques contributed 91.8% to non-obstructive lumen narrowing, while mixed and calcified plaques contributed 89.0% and 65.0% respectively.
MDCT angiography detected a high prevalence of plaques in T2DM patients with TIA or stroke. A relatively high proportion of plaques were non-calcified, as well as with non-obstructive stenosis. MDCT angiography might further enhance the detection and management of carotid and cerebrovascular atherosclerosis in T2DM patients with TIA and stroke
Currently, over 200 million individuals are known to have diabetes mellitus (DM) worldwide and this number is expected to double by the year 2025. Type-2 diabetes mellitus (T2DM) patients frequently have significant carotid stenosis and multiple atherosclerotic plaques, and have higher mortality rates, worse neurologic outcome and more severe disability when they suffer a stroke than those without diabetes[2–4]. Although plaque morphology is not used in the decision making of whether to perform carotid endarterectomy or not, it plays an important role, as it is directly correlated with the risk of embolism and occlusion, thus resulting in cerebral ischaemia (CI). Therefore, it becomes more important to be able to predict the risk of stroke based on the plaque prevalence and morphology.
Conventional digital subtraction angiography (DSA) is considered as the “gold standard” for the evaluation of the degree of carotid and cerebrovascular artery stenosis, but it is unable to make any predictions about plaque type, and this time-consuming method remains invasive and is still associated with catheter-related complications. Thus, several noninvasive imaging modalities such as magnetic resonance imaging (MRI), multidetector computed tomography (MDCT) and duplex ultrasound have been developed for the evaluation of plaque and stenosis, and have been undergoing a rapid development. To our knowledge, few studies systematically investigated the characteristics of carotid and cerebrovascular plaque in T2DM patients with transient ischemic attack (TIA) or stroke by MDCT[7, 8]. The purpose of our study was to evaluate the prevalence and morphology of carotid and cerebrovascular atherosclerotic plaques in a large cohort of T2DM patients with TIA or stroke by using MDCT angiography.
From January 2009 to August 2011, we retrospectively observed 195 consecutive T2DM patients (60.5% men, mean age, 65.7 ± 12.8 years) with neurologic symptoms of TIA or stroke at West China Hospital and Military General Hospital of Chengdu PLA. The presenting neurologic symptoms for all patients were classified as: (1) transient symptoms, i.e., TIA or amaurosis fugax; (2) prior stroke, i.e., any ischemic event with neurologic symptoms. The exclusion criteria for MDCT were known allergy for iodinated contrast agents, renal insufficiency (creatinine level ≥120 μmol/L), pregnancy, and lack of lab or clinical data. All the MDCT examinations were performed within 2 to 4 weeks of neurologic symptom onset. All subjects gave informed consent, and the Ethics Committees of West China Hospital and Military General Hospital of Chengdu PLA approved the study.
Clinical data and diagnostic criteria
Baseline demographics and DM-ralated complications were provided, such as age, gender, age at diabetes diagnosis, duration of DM, hypertension, duration of hypertension, daily smoking, diabetic retinopathy (DR), diabetic foot (DF), diabetic nephropathy (DN), atrial fibrillation (AF), myocardial infarction (MI), and CI. Laboratory tests included measurement of fasting plasma glucose (FPG), triglycerides (TG), total cholesterol (TC), glycosylated hemoglobin (HbAlc), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C). Hypertension was defined as systolic blood pressure of ≥140 mmHg or diastolic blood pressure of ≥90 mmHg. DN was present if the 24-h urinary albumin expression (24-h UAE UA1b) was ≥30 mg (normal, ≤30 mg). CI was confirmed by CT or MRI.
Examinations were performed with 64-MDCT (Siemens Medical Solutions, Forchheim, Germany) (n = 70, from January 2009 to July 2010) at Military General Hospital of Chengdu PLA, DSCT (SOMATOM Definition, Siemens Medical Solutions, Forchheim, Germany) (n = 125, from July 2010 to August 2011) at West China Hospital. For the 64-MDCT group, examinations were performed with the following parameters: 64 row × 0.5 mm detector collimation, 0.5 s/gantry rotation, 120 kV, 350 mA, and 0.94 beam pitch. Unenhanced images were first obtained from lower neck level to mid skull, which was used to determine the scan range of MDCT angiography. Injection of 90 ml of iodinated contrast agent (iopamidol, 370 mg of iodine per milliliter; Bracco Sine Pharmaceutical Corp. Ltd, Shanghai, China), immediately followed by 40 ml of saline chaser solution, was administered through an 18-gauge intravenous antecubital catheter at a flow rate of 6 ml/sec with a dual-head power injector (Stellant; Medrad, Indianola, Penn). DSCT examination was obtained following standard protocols similar to conventional 64-MDCT.
Image reconstructions were performed at 3D image analysis workstation (Syngo-Imaging, Siemens, Medical Solution System, Forchheim, Germany) with the following parameters: a slice thickness of 0.75 mm, and increment of 0.4 mm. The MDCT angiography reader was permitted to utilize any or all of available postprocessing image reconstruction algorithms, including multiplanar reformat (MPR), curved planar reformat (CPR), maximal intensity projection (MIP) or volume rendered technique (VRT).
All data sets were assessed by two independent observers unaware of the clinical history of the patients. In cases where disagreement occurred, agreement was reached in a joint reading.
Continuous variables were expressed as means ± standard deviation (SD). The categorical variables were presented as numbers (percentages). All statistical analyses were per formed using SPSS16.0 (SPSS Inc., Chicago, Ill). P < 0.05 was considered statistically significant.
Clinical charcteristics of the study population (N = 195)
65.7 ± 12.8
Men, n (%)
Age at diabetes diagnosis, years
54.7 ± 11.4
Duration of diabetes, years
6.2 ± 5.4
Smoking, n (%)
Duration of smoking, years
29.1 ± 12.2
Hypertension, n (%)
Duration of hypertension, years
10.3 ± 9.8
Fasting plasma glucose, mmol/L
7.3 ± 2.8
1.7 ± 1.0
Total cholesterol, mmol/L
4.3 ± 0.9
High-density lipoprotein cholesterol, mmol/L
1.2 ± 0.3
Low-density lipoprotein cholesterol, mmol/L
2.3 ± 0.9
Serum uric acid, μmol/l
364.7 ± 103.1
7.9 ± 2.1
Diabetic retinopathy, n (%)
Diabetic foot, n (%)
Diabetic nephropathy, n (%)
Atrial fibrillation, n (%)
Previous myocardial infarction, n (%)
Cerebral infarction, n (%)
Plaque prevalence and morphology
Plaque type and stenosis
In our study, only T2DM patients were enrolled, lack of control group of non-diabetic patients, and the main findings could be summarised as follows: Firstly, in T2DM patients with TIA or stroke, relatively high proportions of plaques were non-calcified and calcified, mainly resulted in non-obstructive stenosis. Secondly, the distributions of plaques were different, non-calcified plaques mainly located in intracranial arteries, both mixed and calcified plaques mainly in intracranial ICA. Finally, the distribution of plaques was extensive, and the most common site of plaque was the cavernous segment of ICA.
In the present study, 42.6% of the plaques are classified as non-calcified plaques, 18.2% as mixed and 39.2% as calcified plaques. Several studies[1, 12] also showed that subjects with diabetes have more non-calcified and calcified plaques and significantly less mixed plaques than those without diabetes. Accordingly, these observations could suggest a more rapid development of atherosclerosis in the presence of diabetes, with faster progression from non-calcified lesions to completely calcified lesions. A faster progression of atherosclerosis had also been suggested previously on the basis of event rates in patients with diabetes undergoing nuclear perfusion imaging. Interestingly, a recent study using MDCT demonstrated that higher proportion of mixed plaque was found in the subjects with diabetes than those without diabetes. But the number of study subjects was small and they were all asymptomatic for cardiac-related symptoms. There is no clear explanation for this difference. It will probably take a larger prospective study to resolve these discordant conclusions. But, despite many controversies, our findings are of clinical importance, since non-calcified plaque may be vulnerable to trigger plaque rupture or embolism, and may be related to the high cerebrovascular disease mortality and morbidity in T2DM patients with TIA or stroke.
Symptomatic patients with carotid stenosis will benefit from carotid endarterectomy or stenting as secondary prevention of ischemic stroke, thus precise carotid and cerebrovascular stenosis quantification is essential. In our study, T2DM patients with TIA or stroke have an obviously higher prevalence of non-obstructive lesions (80.8%), in keeping with previous noninvasive and invasive studies[1, 16, 17]. In a study about coronary artery disease and plaque morphology using 64-MDCT, Scholte et al. revealed that plaques of T2DM patients were mainly non-obstructive (82%). A similar relation between diabetes and non-obstructive plaques has been shown by using invasive coronary angiography in the study of Saely et al.. It has been suggested that non-obstructive plaque is more vulnerable and plaque rupture may occur frequently[16, 18, 19], which may be related to the high mortality and morbidity in T2DM patients with TIA or stroke, and detection of an increased non-obstructive plaque burden using MDCT angiography may therefore be of clinical importance.
We also find that the distributions of plaques are different: non-calcified plaques mainly located in intracranial arteries (80.0%), mixed plaques mainly in intracranial ICA (59.4%), and calcified plaques mainly in intracranial ICA (64.5%) and extracranial arteries (30.4%). Because non-calcified plaques was considered as vulnerable plaques, and mainly located in intracranial arteries, it might partly explain the increased cerebrovascular events in T2DM patients with TIA or stroke, and therefore more aggressive treatment of risk factors in these patients merited further evaluation. Chen et al. reported that the highest prevalence of calcification was seen in the left and right ICA, at about 60%, followed by the right and left vertebral artery, at about 20%. But their study had some limitations. Firstly, the study technology was 16-MDCT. Secondly, the FOV detected was from the skull base to the vertex, not including the carotid. Thirdly, this study included all the patients referred to hospital for brain CT imaging, and only 19.0% patients with a history of diabetes. Furthermore, this was a non-contrast cross-sectional investigation, and could not find non-calcified and mixed plaques.
Additionally, when considering the distribution of plaques, we find that the most common site of plaque is the cavernous portion of ICA in T2DM patients with TIA or stroke. Fields et al. reported that stenosis of the intracranial ICA was less common, and was usually located between the carotid canal and the origin of the ophthalmic artery. Wojak et al. also revealed that intracranial atherosclerotic stenosis typically occurred in the petrous cavernous siphon segments of the ICA. Masuoka et al. explored the cause of development of atheromatous plaque around the cavernous portion of the ICA using serial 3-mm sections of 32 intracranial ICAs obtained from 50 cadavers, and found that the external elastic lamina disappeared in the cavernous portion of the ICA, and intimal thickening of the ICA frequently appeared in the horizontal segment of the cavernous portion of the ICA, which was the most common site of stenosis of the intracranial ICA. They suggested that change in the elasticity of the arterial wall in the cavernous portion might be an important factor in the process of atherosclerosis in the intracranial ICA.
Outlining the significance of our study, the prevalence and morphology of carotid and cerebrovascular atherosclerotic plaques in T2DM patients with TIA or stroke by 64-MDCT and DSCT angiography is reported comprehensively and systematically. Secondly, the uniqueness of our study lies in the scanner technology, which has better visualization of arteries with calcified plaque or vessels located next to the skull bone than early CT[24, 25]. In the present study, bone-subtraction CTA was simple and user-independent, and thereby it was more acceptable for routine clinical work than other noninvasive angiographies. Ultrasound analysis still remained user dependent, for example, and Corriveau et al. reported that interobserver variability of Doppler sonography in analysis of degree of stenosis was suboptimal. Thirdly, the MDCT angiography findings, which depend on a large study sample, can reflect relatively accurate characteristics of plaque and stenosis in T2DM patients with TIA or stroke, and can be used to conduct a further treatment plan.
Limitations are there. Firstly, only T2DM patients were studied, lack of a control group of non-T2DM patients, and data concerning the prevalence of atherosclerosis as determined by MDCT in larger populations are needed. Secondly, the capabilities of current generation CT in the evaluation of disease involving small and very small arteries with an average diameter of 1.5 mm or less have not been well characterized. Finally, MDCT is still associated with a risk of radiation dose, and administration of contrast media is also required.
MDCT angiography detected a high prevalence of plaques in T2DM patients with TIA or stroke. A relatively high proportion of plaques were non-calcified, as well as with non-obstructive stenosis. MDCT angiography might further enhance the detection and management of carotid and cerebrovascular atherosclerosis in T2DM patients with TIA and stroke.
This work was supported by Science Foundation of Military General Hospital of Chengdu PLA (NO. 2011YG-B38) and 12th Five-year Science Plan of Chengdu Military (NO.C12036).
- Scholte AJ, Schuijf JD, Kharagjitsingh AV, Jukema JW, Pundziute G, van der Wall EE, Bax JJ: Prevalence of coronary artery disease and plaque morphology assessed by multi-slice computed tomography coronary angiography and calcium scoring in asymptomatic patients with type 2 diabetes. Heart. 2008, 94: 290-295. 10.1136/hrt.2007.121921.View ArticlePubMedGoogle Scholar
- Oppenheimer SM, Hoffbrand BI, Oswald GA, Yudkin JS: Diabetes mellitus and early mortality from stroke. Br Med J (Clin Res Ed). 1985, 291: 1014-1015.View ArticleGoogle Scholar
- Kushner M, Nencini P, Reivich M, Rango M, Jamieson D, Fazekas F, Zimmerman R, Chawluk J, Alavi A, Alves W: Relation of hyperglycemia early in ischemic brain infarction to cerebral anatomy, metabolism, and clinical outcome. Ann Neurol. 1990, 28: 129-135. 10.1002/ana.410280204.View ArticlePubMedGoogle Scholar
- Kiers L, Davis SM, Larkins R, Hopper J, Tress B, Rossiter SC, Carlin J, Ratnaike S: Stroke topography and outcome in relation to hyperglycaemia and diabetes. J Neurol Neurosurg Psychiatry. 1992, 55: 263-270. 10.1136/jnnp.55.4.263.PubMed CentralView ArticlePubMedGoogle Scholar
- Dawkins AA, Evans AL, Wattam J, Romanowski CA, Connolly DJ, Hodgson TJ, Coley SC: Complications of cerebral angiography: a prospective analysis of 2,924 consecutive procedures. Neuroradiology. 2007, 49: 753-759. 10.1007/s00234-007-0252-y.View ArticlePubMedGoogle Scholar
- Rotter M, Pfiffner D, Maier W, Zeiher AM, Meier B: Interventional cardiology in Europe 1999. Eur Heart J. 2003, 24: 1164-1170. 10.1016/S0195-668X(03)00205-7.View ArticlePubMedGoogle Scholar
- Lell M, Fellner C, Baum U, Hothorn T, Steiner R, Lang W, Bautz W, Fellner FA: Evaluation of carotid artery stenosis with multisection CT and MR imaging: influence of imaging modality and postprocessing. AJNR Am J Neuroradiol. 2007, 28: 104-110.View ArticlePubMedGoogle Scholar
- Ibebuogu UN, Nasir K, Gopal A, Ahmadi N, Mao SS, Young E, Honoris L, Nuguri VK, Lee RS, Usman N, Rostami B, Pal R, Flores F, Budoff MJ: Comparison of atherosclerotic plaque burden and composition between diabetic and non diabetic patients by non invasive CT angiography. Int J Cardiovasc Imaging. 2009, 25: 717-723. 10.1007/s10554-009-9483-9.View ArticlePubMedGoogle Scholar
- Ruilope LM, Garcia-Puig J: Hyperuricemia and renal function. Curr Hypertens Rep. 2001, 3: 197-202. 10.1007/s11906-001-0038-2.View ArticlePubMedGoogle Scholar
- North American Symptomatic Carotid Endarterectomy Trial Collaborators: Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 1991, 325: 445-453.http://www.ncbi.nlm.nih.gov/pubmed/1852179,View ArticleGoogle Scholar
- Ballotta E, Da Giau G, Renon L: Carotid plaque gross morphology and clinical presentation: a prospective study of 457 carotid artery specimens. J Surg Res. 2000, 89: 78-84. 10.1006/jsre.1999.5809.View ArticlePubMedGoogle Scholar
- Pundziute G, Schuijf JD, Jukema JW, Boersma E, Scholte AJ, Kroft LJ, van der Wall EE, Bax JJ: Noninvasive assessment of plaque characteristics with multislice computed tomography coronary angiography in symptomatic diabetic patients. Diabetes Care. 2007, 30: 1113-1119. 10.2337/dc06-2104.View ArticlePubMedGoogle Scholar
- Giri S, Shaw LJ, Murthy DR, Travin MI, Miller DD, Hachamovitch R, Borges-Neto S, Berman DS, Waters DD, Heller GV: Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease. Circulation. 2002, 105: 32-40. 10.1161/hc5001.100528.View ArticlePubMedGoogle Scholar
- Zeina AR, Odeh M, Rosenschein U, Zaid G, Barmeir E: Coronary artery disease among asymptomatic diabetic and nondiabetic patients undergoing coronary computed tomography angiography. Coron Artery Dis. 2008, 19: 37-41. 10.1097/MCA.0b013e3282f2f19e.View ArticlePubMedGoogle Scholar
- Barnett HJ, Taylor DW, Eliasziw M, Fox AJ, Ferguson GG, Haynes RB, Rankin RN, Clagett GP, Hachinski VC, Sackett DL, Thorpe KE, Meldrum HE, Spence JD: Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med. 1998, 339: 1415-1425. 10.1056/NEJM199811123392002.View ArticlePubMedGoogle Scholar
- Saely CH, Aczel S, Marte T, Langer P, Drexel H: Cardiovascular complications in Type 2 diabetes mellitus depend on the coronary angiographic state rather than on the diabetic state. Diabetologia. 2004, 47: 145-146. 10.1007/s00125-003-1274-6.View ArticlePubMedGoogle Scholar
- Chu ZG, Yang ZG, Dong ZH, Zhu ZY, Peng LQ, Shao H, He C, Deng W, Tang SS, Chen J: Characteristics of coronary artery disease in symptomatic type 2 diabetic patients: evaluation with CT angiography. Cardiovasc Diabetol. 2010, 9: 74-10.1186/1475-2840-9-74.PubMed CentralView ArticlePubMedGoogle Scholar
- Wackers FJ: Asymptomatic patients with diabetes mellitus should be screened for coronary artery disease. J Nucl Cardiol. 2006, 13: 609-615. 10.1016/j.nuclcard.2006.06.129.View ArticlePubMedGoogle Scholar
- Virmani R, Burke AP, Farb A, Kolodgie FD: Pathology of the vulnerable plaque. J Am Coll Cardiol. 2006, 47: C13-C18. 10.1016/j.jacc.2005.10.065.View ArticlePubMedGoogle Scholar
- Chen XY, Lam WW, Ng HK, Fan YH, Wong KS: The frequency and determinants of calcification in intracranial arteries in Chinese patients who underwent computed tomography examinations. Cerebrovasc Dis. 2006, 21: 91-97. 10.1159/000090206.View ArticlePubMedGoogle Scholar
- Fields WS, Lemak NA: Joint study of extracranial arterial occlusion X. Internal carotid artery occlusion. JAMA. 1976, 235: 2734-2738. 10.1001/jama.1976.03260510028020.View ArticlePubMedGoogle Scholar
- Wojak JC, Dunlap DC, Hargrave KR, DeAlvare LA, Culbertson HS, Connors JJ: Intracranial angioplasty and stenting: long-term results from a single center. AJNR Am J Neuroradiol. 2006, 27: 1882-1892.PubMedGoogle Scholar
- Masuoka T, Hayashi N, Hori E, Kuwayama N, Ohtani O, Endo S: Distribution of internal elastic lamina and external elastic lamina in the internal carotid artery: possible relationship with atherosclerosis. Neurol Med Chir (Tokyo). 2010, 50: 179-182. 10.2176/nmc.50.179.View ArticleGoogle Scholar
- Suzuki M, Ozaki Y, Komura S, Nakanishi A: Intracranial carotid calcification on CT images as an indicator of atheromatous plaque: analysis of high-resolution CTA images using a 64-multidetector scanner. Radiat Med. 2007, 25: 378-385. 10.1007/s11604-007-0153-3.View ArticlePubMedGoogle Scholar
- Zhang LJ, Wu SY, Niu JB, Zhang ZL, Wang HZ, Zhao YE, Chai X, Zhou CS, Lu GM: Dual-energy CT angiography in the evaluation of intracranial aneurysms: image quality, radiation dose, and comparison with 3D rotational digital subtraction angiography. AJR Am J Roentgenol. 2010, 194: 23-30. 10.2214/AJR.08.2290.View ArticlePubMedGoogle Scholar
- Corriveau MM, Johnston KW: Interobserver variability of carotid Doppler peak velocity measurements among technologists in an ICAVL-accredited vascular laboratory. J Vasc Surg. 2004, 39: 735-741. 10.1016/j.jvs.2003.12.017.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.